Inventor
GAO CHANGSHOU
US34 patents
⚠️ This page may combine multiple inventors who share the name “GAO CHANGSHOU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIMMUNE LLC
20 patentsUS7790655B2Sep 7, 2010
Cell display of antibody libraries
MEDIMMUNE LLC36 citations92
US7659374B2Feb 9, 2010
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
MEDIMMUNE LLC28 citations92
US7585504B2Sep 8, 2009
High affinity antibodies against HMGB1 and methods of use thereof
MEDIMMUNE LLC21 citations92
US10442854B2Oct 15, 2019
Neutralizing anti-influenza binding molecules and uses thereof
MEDIMMUNE LLC13 citations91
US10744204B2Aug 18, 2020
Conjugated compounds comprising cysteine-engineered antibodies
MEDIMMUNE LLC8 citations82
US9580509B2Feb 28, 2017
Multispecific and multivalent binding proteins and uses thereof
MEDIMMUNE LLC9 citations82
US7964706B2Jun 21, 2011
High affinity antibodies against HMGB1 and methods of use thereof
MEDIMMUNE LLC10 citations82
US10457732B2Oct 29, 2019
Bispecific binding proteins and uses thereof
MEDIMMUNE LLC10 citations81
US10882897B2Jan 5, 2021
Neutralizing anti-influenza binding molecules and uses thereof
MEDIMMUNE LLC3 citations71
US10597439B2Mar 24, 2020
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
MEDIMMUNE LLC4 citations71
USRE49908EApr 9, 2024
Bispecific binding proteins and uses thereof
MEDIMMUNE LLC1 citations70
US11279759B2Mar 22, 2022
Bispecific binding proteins and uses thereof
MEDIMMUNE LLC4 citations70
US10160812B2Dec 25, 2018
Bispecific HER2 antibodies
MEDIMMUNE LLC4 citations69
US9120875B2Sep 1, 2015
HSA-related compositions and methods of use
MEDIMMUNE LLC4 citations69
US11192931B2Dec 7, 2021
Relaxin fusion polypeptides and uses thereof
MEDIMMUNE LLC2 citations68
US9567389B2Feb 14, 2017
Cell display of antibody libraries
MEDIMMUNE LLC1 citations63
US11926657B2Mar 12, 2024
Neutralizing anti-influenza binding molecules and uses thereof
MEDIMMUNE LLC0 citations61
US11524993B2Dec 13, 2022
Neutralizing anti-influenza binding molecules and uses thereof
MEDIMMUNE LLC0 citations61
US11414477B2Aug 16, 2022
Methods for preparing antibodies with a defined glycosylation pattern
MEDIMMUNE LLC0 citations56
US11759526B2Sep 19, 2023
Method and molecules
MEDIMMUNE LLC0 citations51
MEDIMMUNE LTD
7 patentsUS11203633B2Dec 21, 2021
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
MEDIMMUNE LTD2 citations71
US12428473B2Sep 30, 2025
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
MEDIMMUNE LTD0 citations61
US11845782B2Dec 19, 2023
Relaxin fusion polypeptides and uses thereof
MEDIMMUNE LTD0 citations58
US11634483B2Apr 25, 2023
Nucleic acids encoding anti-VEGF-A antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US11566068B2Jan 31, 2023
Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US10919958B2Feb 16, 2021
Anti-VEGF-A antibodies and uses thereof
MEDIMMUNE LTD0 citations58
US10836819B2Nov 17, 2020
Anti-VEGF-A and anti-ANG2 antibodies and uses thereof
MEDIMMUNE LTD0 citations48
GAO CHANGSHOU
3 patentsSCRIPPS RESEARCH INST
2 patentsUS6472147B1Oct 29, 2002
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
SCRIPPS RESEARCH INST141 citations98
US7078166B2Jul 18, 2006
Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries
SCRIPPS RESEARCH INST3 citations62